{
    "medicine_id": "6d999743f16ec2ed52e2b21d02828693230e4312",
    "platform_id": "DB15622",
    "metadata": {
        "name": "Fluzone Quadrivalent Southern Hemisphere 15 mcg Suspension",
        "composition": "15 mcg Triazavirin",
        "clinical_particulars": {
            "therapeutic_indications": "Triazavirin was developed in Russia as a potential treatment of Influenza A and B infections A191706",
            "contraindications": {
                "disease": "The intraperitoneal LD sub 50 sub of triazavirin in mice is 1400 120mg kg in mice and the intragastric LD sub 50 sub is 2200 96mg kg A191706 Patients experiencing an overdose may present with nausea vomiting dyspepsia and stomach pain L12165 Treat overdose with symptomatic and supportive treatment which may include discontinuation of treatment L12165",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}